 |
About Us |
 |
 |
|
|
| Key Management & Scientific |
Dr. Raj (SB) Rajur, PhD, Founder, Chairman and CEO
Dr. Rajur established CreaGen BioSciences, Inc. as an early stage discovery research service provider and it has now evolved into a well-known collaborative research organization. Under his leadership, CreaGen collaborates with a number of multinational pharmaceutical and biotech companies and recently expanded to an offshore facility in Bangalore, India.
Dr Rajur holds a PhD degree in synthetic and organic chemistry and has enjoyed a distinguished career in the academic community and the pharmaceutical industry with a broad range of experience in medicinal chemistry and drug discovery. He has authored more than 25 papers in peer-reviewed journals and holds three US patents.
Dr. Rajur's academic career includes appointments at the Southwestern Medical Center in Dallas, Boston College, Northeastern University, Massachusetts General Hospital and Harvard Medical School. In the industrial sector, he has held scientific and managerial positions at ArQule and Millipore Corporations. At ArQule, Dr. Rajur supervised collaborations with Bayer, Pfizer and Amersham Pharmacia Biosciences. Dr. Rajur also significantly contributed to ArQule's internal drug discovery programs, specifically the ion channel, kinase and GPCR programs. Products co-developed by Dr. Rajur have been used in drug discovery efforts at Clonetech Laboratories in Palo Alto, CA.
Dr. Rajur's expertise is with small molecule drug discovery, specifically targeted towards cancer and anti-infective therapeutics and the development of prodrug pharmaceuticals.
Dr. Rajur serves as the reviewer for the ACS Journal of Pharmaceutical Sciences and presently is Councilor and Program Chair for the Medicinal Chemistry Division of the Northeastern Section of the American Chemical Society. |
Norton P. Peet, PhD, SAB Chair
Dr. Peet received his PhD degree from the University of Nebraska followed by a postdoctoral appointment at the Massachusetts Institute of Technology. Dr. Peet was founder and CEO of Aurigene Discovery Technologies, V.P. of Discovery Alliances at ArQule, and Head of Medicinal Chemistry and Distinguished Scientist at Aventis. Dr. Peet serves on several editorial boards and has authored 145 technical articles and books. He holds 65 US Patents, which largely cover enzyme inhibitors and receptor ligands for therapeutic targets in the areas of CNS, cardiovascular, metabolic and respiratory diseases, and oncology. Dr. Peet is active in the scientific community; he has organized and chaired several international symposia, he is a member of the IBC USA Board, and locally he has organized and chaired several NESACS Medicinal Chemistry Symposia.
|
Hwa-Ok Kim, PhD, Director of Chemistry
Dr. Kim received his PhD degree from New Mexico State University and then entered his postdoctoral appointment at Marion Merrell Dow. Dr. Kim served as Director of Chemistry at Aurigene Discovery Technologies, where he directed all global partnered chemistry programs. Prior to that, as Project Leader at Molecumetics, he managed five partnered projects, company internal projects, and High Throughput Organic Synthesis (Automation Synthesis) for collaborations with more than $10M revenue. Dr. Kim has authored more than 40 technical articles and books and holds ten US Patents. |
Financial Advisor |
Mr. Vimal Raheja, MBA, CPA
Mr. Raheja received his BA degree from the University of Massachusetts, Amherst, MA, his MBA degree from Suffolk University, Boston, MA, and his MSA degree from Bentley College, Waltham, MA. He is a member of the American Institute of Certified Public Accountants and also a member of the Massachusetts Society of Certified Public Accountants. |
|
|
|
|
Company Profile |
|
 |
CreaGen Biosciences, Inc. is located in Woburn, MA, on the near north side of the Greater Boston Area. Boston is one of the primary hubs in the world for life sciences research.
(Corporate Fact Sheet)
more...
|
|
|
News |
|
 MassBi CRO CMO Symposium: February 25th, 2013
CreaGen Biosciences’ CEO is Co-Chair of the Second Annual Massachusetts CRO/CMO Symposium
CreaGen Biosciences will be one of the 40+ companies exhibiting at the February 25th event that showcases the local service providers from the greater MA life sciences cluster
http://www.massbio.org/events/calendar/1764-ma_cro_cmo_symposium/event_detail/452. more... |
|
2012
Raj Rajur attends TiECON East Conference as Charter Member together with Governor Deval Patrick.
Several Pictures from the Event: more... |
|
2012
MA CRO/CMO Symposium: Accelerating Drug Development
A One Day Symposium Presented by MassBio's Massachusetts CRO CMO Committee
Symposium will feature addresses by:
Deval Patrick, Governor of Massachusetts or Timothy Murray, Lieutenant Governor State of Massachusetts
The Conference Center at Bentley University, 75 Forest Street, LaCava 300, Waltham, MA 02452
March 6, 2012 7:30 a.m. to 4:00 p.m.
More Details more... |
|
| |
| |
|
